Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

NEW
FRA:BT3 (USA)  
€ 1.036 (0%) Jul 16
At Loss
P/B:
5.42
Market Cap:
€ 256.13M ($ 292.89M)
Enterprise V:
€ 210.33M ($ 240.51M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Lineage Cell Therapeutics Inc Valuation Measures